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The report describes new technologies in generation and collection of biological nanoaerosol (NA) de-
veloped in the laboratory of Nanostructures and Nanotechnologies, ITEB RAS. NA generator to be used for 
pulmonary delivery of antibiotics, anti-inflammatory and other drugs and vaccines employs a new atomiza-
tion principle based on a gas-phase neutralization of electrospray-generated drug nanoclusters with small 
counter-ions produced by electrospraying of a volatile solvent like ethanol. It was demonstrated that a va-
riety of biological substances including proteins can be atomized into NA of 20-100 nm in size, using this 
generator without affecting functional properties of the atomized substance. Several approaches have been 
developed to measure doses of inhaled NA including standard condensation particle counter, quartz reso-
nator and filters from polyvinylpirrolidone nanofibers. It was demonstrated that water-soluble electrospun 
nanofilters may also be employed to capture pathogens and pathogen biomarkers for analysis of nosocomi-
al infections in clinics wards, in collection of non-volatile biomarkers in the exhaled breath, in testing 
working places for NA pollution and in other applications. 
 
Keywords: Biological nanoaerosol, Inhaled drugs, Generator, Dosimeter, Electrospun nanofilters, Aerosol 
collection. 
 
 PACS numbers: 87.85.Qr, 87.85.Rs 
 
 
                                                        
* vmorozov@gmu.edu 
1. INTRODUCTION 
 
Nanoaerosols attracted a great attention recently 
for two main reasons. First, products and materials 
containing nano-components (nanoparticles and nano-
fibers) aggressively enter the market. These compo-
nents may eventually become airborne and penetrate 
into lung. Biological effects of such nanoaerosols (NA), 
are far from being clear, especially upon a prolonged 
exposure. Second, NA may be efficiently employed to 
deliver drugs via pulmonary route. Their ability to pen-
etrate deep into alveoli is beneficial in treatment of 
lung diseases and allows bypassing destruction in the 
digestive tract and in the liver upon the first passage. 
Though advantages of the nanoaerosolized drugs are 
well recognized [1, 2] their practical usage has been 
restricted due to lack of good means to produce NA and 
to determine the inhaled doses.  
In this paper we describe our new approaches to 
generation, detection and dosimetry of biological NA, 
aiming at development of a new administration route 
for drugs and other biomedical applications of NA. 
 
2. NANOAERSOL GENERATION 
 
2.1 Principle of Nanoaerosol Generation 
 
A new principle of generation of biological NA is il-
lustrated in Fig. 1. A solution is electrosprayed in a 
closed chamber and the electrosprayed cloud is neutral-
ized with a cloud of counter-ions produced by elec-
trospraying of a volatile solvent like ethanol. It has 
been demonstrated that even fragile biomolecules, like 
proteins retained their structure and functional proper-
ties, e.g., enzyme activity in NA produced with this 
technique [3, 4].  
 
 
 
Fig. 1 – Principle of nanoaersol generation by neutralization 
of a cloud of electrosprayed charged drug nanoclusters from a 
capillary at a positive potential with a cloud of small 
negatively charged ions generated by electrospraying of a 
volatile solvent at a negative potential 
 
Fig. 2 illustrated the last version of a nanoaerosol 
generator designed in the laboratory for experimenting 
with small animals. It differs from the earlier versions 
described in ref. [3] in several improvements aiming at 
obtaining higher stability, better control of the NA 
yield and other important functional features.  Using 
solutions of proteins, antibiotics and other substances it 
was demonstrated that the generator produces NA with 
a concentration up to 107 NP/cm3 with an average size 
changing between 20 nm and 100 nm depending on the 
solution concentration, voltage, airflow and on other 
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parameters. Great attention has been paid to develop 
methods for monitoring NP concentration and doses 
obtained by animals. In particular, a crystal quartz 
dosimeter and filter-based probes were developed to 
measure the overall dose and NA concentrations.  
 
 
 
Fig. 2 – The latest prototype of a generator for production of 
biological nanoaerosol. Air pumps and flow meters are not 
shown in the picture 
 
2.2 Applications of Nanoaerosolized Drugs 
 
We envisage many potential applications of the 
nanoaerosol technology both in biomedical research and 
in medical practice. It has been demonstrated by a group 
of Russian scientists that when inhaled by mice NA of 
anti-inflammatory drugs, ibuprofen and indomethacin, 
were active at doses which are million times lower than 
those administered orally [1, 2]. This decrease in the 
doses is partly explained by the fact that the drugs in-
haled in the form of NA avoid digestion in the stomach 
and upon the first passage through the liver.  Therefore, 
the pulmonary route opens an opportunity for other 
drugs to considerably reduce doses and, hence, the side 
effects. In collaboration with the National Center for 
Biodefense and Infectious Diseases of the George Mason 
University (Manassas, VA, USA) our laboratory explores 
applicability of the NA generator described above to vac-
cination and treatment of mice infected with tularemia. 
 
3. COLLECTION OF BIOLOGICAL NANOAERO-
SOLS WITH ANALYTICAL WATER-SOLUBLE 
NANOFILTERS 
 
Nanoaerosols cannot be collected using conventional 
inertial devices like impactors and cyclones. We devel-
oped nanofilters from water-soluble polymers to collect 
micro- and nano-aerosol particles and to transfer them 
into a small volume of buffer for further biochemical or 
genetic analysis. Nanofilters are manufactured using a 
modified electrospinning technology [5-8] in which 
charged nanofibers are neutralized by a cloud of coun-
ter-ions in a way similar to that illustrated in Fig. 1. 
Such filters enable collection of aerosols at a high veloci-
ty (up to 1 m3/min) and allow to completely transfer the 
collected material into 10-20 L of buffer solution upon 
the filter dissolution. One simple prototype of such nano-
filter is presented in Fig. 3. As illustrated in Fig. 4. wa-
ter-soluble nanofilter collects all micro- and sub-micro 
aerosol particles with a size exceeding 150-170 nm and 
most of the smaller NA. Such filters were shown to work 
at a relative humidity lower than 75 % [5].  
 
 
 
Fig. 3 – A simple collector of aerosol and NA based on use of a 
water-soluble nanofilter 
 
 
 
Fig. 4 – Efficiency of NA collection with a water-soluble 
nanofilter from PVP. Blue line presents NA spectrum 
generated by the NA generator from a sucrose solution. Black 
line – spectrum of the same NA after passing through the 
filter. “Diffusion” and “Sieve” marks denote different 
mechanisms of NA capturing 
 
3.1 Where Analytical Nanofilters Could Be 
Used? 
 
These nanofilters are widely used in our laboratory 
for many purposes: (i) to measure the overall produc-
tion of NA in the generator described above; (ii) in col-
lection of pathogens and their biological markers in-
doors; (iii) in collection of “human dust” – micro- and 
nanoparticles exhaled and lost from skin and clothes. 
Such filters could also be used for evaluation of air pol-
lution with nanoparticles in industrial buildings [9].  
 
3.2 Collection of Exhaled Non-volatile Biologi-
cal Markers  
 
One application of water-soluble nanofilters which 
is under development in our laboratory is a non-
invasive technique for obtaining probes of lung liquid 
by collection of dry residues of lung nanodroplets in the 
exhaled air. Conventional procedure which is employed 
for obtaining probes of lung liquid (bronchoalveolar 
lavage) includes washing lung with a physiological so-
lution. In our approach nanodroplets of lung liquid are 
first dried by heating the exhaled air and then collected 
on a water-soluble nanofilter, as illustrated schemati-
cally in Fig. 5. Several prototypes of the device have 
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been tested in the laboratory (see one version illustrat-
ed in Fig. 6). As compared to the conventional tech-
nique of collecting exhaled breath condensate (EBC) 
dissolution of water-soluble nanofilter after collection 
provides much more concentrated samples which re-
quire less expensive and sophisticated techniques for 
analysis of biomarkers. 
 
 
 
Fig. 5 – Schematic of a device used for collection of non-
volatile biomarkers in the exhaled breath using water-soluble 
nanofilters 
 
 
 
Fig. 6 – Collection of exhaled biomarkers with a water-soluble 
nanofilter from PVP 
 
 
 
3.3 Use of Analytical Nanofilters in Detection of 
Airborne Tuberculosis Markers 
 
Water-soluble nanofilters manufactured by electro-
spinning of PVP solutions were also employed to col-
lect aerosol in a tuberculosis clinic. A filter attached 
to a headpiece of a household vacuum cleaner allowed 
to collect aerosol at a flow rate of 0.6 m3/min from a 
ward volume of 9 m3 in 15 minutes. Dissolution of the 
filter liberated all the collected aerosol particles in 
0.1-0. mL of water. Quantitative assay of M. tubercu-
losis DNA was based on the real-time PCR using the 
multi-copy insertion sequence, IS6110, and the single-
copy fragment of the regX3 gene as primers and fluo-
rogenic hybridization probes. Effect of the filter mate-
rial on the assay efficiency was estimated by analysis 
of a vaccine strain, BCG. Probes were collected in 
each of the 21 hospital wards and tested for the MTB 
DNA. In 5 of them occupied by patients (excreting 
MTB according to microscopic tests) MTB DNA was 
detected on the nanofilters in the PCR assay. In 4 of 
these wards ~ 100 copies of the multi-copy primer, 
IS6110, was discovered. In one ward occupied with a 
patient having a massive excretion of TB we found as 
many as 5·102 fragments of IS6110 gene and 
~ 10 copies of the regX3 gene on the filter. Thus, wa-
ter-soluble filters enable a simple, rapid and highly 
efficient technique for collection of aerosols into a 
small volume of liquid probe. The presence of DNA in 
the probe could be detected by the real-time PCR as-
say.  Combination of these two techniques allows to 
control contamination of air with TB and other bacte-
ria and prevent hospital-acquired nosocomial infec-
tions. 
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